MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss for the year
-$11,912K
Loss before income
taxes
-$11,909K
Income tax
$3K
Operating loss
-$11,632K
Financial expenses
$277K
Total operating
expenses
$11,632K
Research And Development
$7,140K
General And
Administrative
$4,492K
Back
Back
Income Statement
source: myfinsight.com
Silexion Therapeutics Corp (SLXN)
Silexion Therapeutics Corp (SLXN)